TriNetX EHR analysis of 16,569 vitiligo patients versus matched controls demonstrated higher rates of depression, anxiety, panic disorder, insomnia, and nonorganic sexual dysfunction, with slightly ...
Centanafadine XR 280 mg QD significantly reduced AISRS total scores at week 8 versus placebo (LS mean change -18.5 vs -12.6; treatment difference -5.87). Improvement in comorbid anxiety was ...
Zanubrutinib plus rituximab demonstrated a clinically meaningful progression-free survival advantage over bendamustine plus rituximab in previously untreated MCL, with a 43% risk reduction for ...
Broad formulary uptake includes unrestricted access via UnitedHealthcare, Express Scripts, Cigna, Optum Rx, and TRICARE, with prior authorization common among some Blue Cross plans and CVS Caremark.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results